INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 15, 2003 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Sep 16, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,031 | $349.12 | 22,364,543 |
| Jan 05, 2005 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 15,035 | -- | -- |
| Jan 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,066 | -- | 16,666 |
| Dec 23, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,104 | $389.17 | 22,713,305 |
| Aug 01, 2011 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,144 | $15.64 | 15,144 |
| Aug 01, 2011 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,144 | -- | 10,428 |
| May 13, 2019 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 15,147 | $304.20 | 32,303 |
| Apr 27, 2009 |
VP Regul Devel & Clin Safety
Trans History: 288
|
VP Regul Devel & Clin Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,160 | $6.50 | 82,116 |
| Apr 27, 2009 |
VP Regul Devel & Clin Safety
Trans History: 288
|
VP Regul Devel & Clin Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 15,160 | $12.74 | 66,956 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.